Med Holdings Group Inc. is in advanced negotiations with nationally recognized urology and sexual wellness specialist Dr. Harvey Samowitz, a move the company states would significantly strengthen its clinical leadership during rapid expansion. Dr. Samowitz brings more than 30 years of experience in urology, sexual medicine, and pelvic health and is board certified by the American Board of Urology. This potential partnership represents a strategic effort by Med Holdings Group to align with elite medical professionals as it scales operations. Chief Executive Officer Jessica Miller stated the company's strategy involves aligning with top medical leadership, scaling into high-demand markets, accelerating compliance milestones, and building a nationally recognized brand.
Concurrently, Med Holdings Group is actively expanding into high-growth markets with negotiations underway for two additional locations in Jupiter, Florida and Doral, Florida. Management believes these markets align directly with the company's demographic strategy and high-income target base, anticipating these additions will materially strengthen recurring revenue and regional brand dominance. The company is also accelerating completion of its audit process while advancing its FINRA name change and ticker symbol change to enhance transparency and increase market visibility.
A significant development in the company's expansion strategy is the official launch of its enhanced national platform at https://TotallBody.com, which significantly expands its addressable market beyond physical locations. The platform provides immediate national brand exposure, access to a large underserved U.S. market, and scalable digital engagement for services and future vertical expansion. Management views this as a foundational step toward building a nationally scalable healthcare platform that complements the physical expansion strategy.
Market momentum appears favorable for the company, with its stock appreciating more than 500% over the past twelve months and market capitalization now exceeding $3 million. Management believes this growth reflects increasing investor awareness and recognition of the company's strategic direction and execution. With committed expansion capital, a clear acquisition and multi-location rollout strategy, accelerating compliance milestones, expanding clinical leadership, and a scalable national digital infrastructure, Med Holdings Group believes it is strategically positioned for continued operational and market growth into 2026 and beyond. The combination of elite clinical expertise through potential partnerships like Dr. Samowitz's, physical market expansion, and digital platform development creates a comprehensive growth framework that addresses multiple aspects of healthcare delivery and market penetration.
